Last updated on April 21, 2014 at 5:04 EDT

Latest Jeffrey Bacha Stories

2013-09-09 08:27:28

Advisory Board to Oversee Clinical Studies in China to Support Product Growth and Repositioning of VAL-083 VANCOUVER, British Columbia, MENLO PARK, Calif., and WUZHOU, China, Sept. 9, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") and Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd., a subsidiary of Guagxi Wuzhou Zhongeng Group Co., Ltd. (SHG 600252) today announced that the companies have established a clinical advisory board to oversee new clinical studies aimed...

2012-11-08 08:35:29

VANCOUVER, British Columbia, Nov. 8, 2012 /PRNewswire/ -- Del Mar Pharmaceuticals (BC) Ltd. (DelMar) today announced that Mr. Jeffrey Bacha, the Company's President & CEO, delivered the keynote address entitled VAL-083 a Novel Chemotherapeutic Agent Developed in China for CML and Lung Cancer Shows Potential to Surpass Standard of Care in Glioblastoma Multiforme at the 2012 International Drug Discovery Science and Technology Conference in Nanjing, China. In his address, Mr. Bacha...